Joseph Kohn

1.1k total citations
50 papers, 859 citations indexed

About

Joseph Kohn is a scholar working on Applied Microbiology and Biotechnology, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Joseph Kohn has authored 50 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Applied Microbiology and Biotechnology, 28 papers in Epidemiology and 21 papers in Clinical Biochemistry. Recurrent topics in Joseph Kohn's work include Antibiotic Use and Resistance (31 papers), Bacterial Identification and Susceptibility Testing (21 papers) and Urinary Tract Infections Management (12 papers). Joseph Kohn is often cited by papers focused on Antibiotic Use and Resistance (31 papers), Bacterial Identification and Susceptibility Testing (21 papers) and Urinary Tract Infections Management (12 papers). Joseph Kohn collaborates with scholars based in United States, United Kingdom and Canada. Joseph Kohn's co-authors include P. Brandon Bookstaver, Majdi N. Al‐Hasan, Julie Ann Justo, Helmut Albrecht, Geoffrey B. Smith, G. Hamilton Fairley, R Powles, Traci L. Testerman, Piet Vos and Alex Robertson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Joseph Kohn

49 papers receiving 838 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Kohn United States 17 393 368 367 241 194 50 859
Y. Péan France 15 247 0.6× 417 1.1× 201 0.5× 240 1.0× 327 1.7× 38 998
Joe Amoah United States 16 240 0.6× 335 0.9× 149 0.4× 180 0.7× 128 0.7× 25 712
Galia Kariv Israel 6 248 0.6× 385 1.0× 341 0.9× 143 0.6× 104 0.5× 7 740
Elodie von Dach Switzerland 15 208 0.5× 423 1.1× 164 0.4× 209 0.9× 365 1.9× 35 1.0k
Sang Yop Shin South Korea 14 166 0.4× 365 1.0× 148 0.4× 464 1.9× 128 0.7× 36 848
Weihong Fan United States 12 176 0.4× 193 0.5× 141 0.4× 239 1.0× 150 0.8× 25 564
Sorabh Dhar United States 18 214 0.5× 239 0.6× 134 0.4× 444 1.8× 236 1.2× 55 931
Yaakov Dickstein Israel 14 139 0.4× 193 0.5× 177 0.5× 155 0.6× 104 0.5× 24 622
Jeannie D. Chan United States 20 133 0.3× 267 0.7× 149 0.4× 106 0.4× 140 0.7× 53 1.1k
Lesley Palmay Canada 10 360 0.9× 218 0.6× 123 0.3× 137 0.6× 132 0.7× 20 607

Countries citing papers authored by Joseph Kohn

Since Specialization
Citations

This map shows the geographic impact of Joseph Kohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Kohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Kohn more than expected).

Fields of papers citing papers by Joseph Kohn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Kohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Kohn. The network helps show where Joseph Kohn may publish in the future.

Co-authorship network of co-authors of Joseph Kohn

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Kohn. A scholar is included among the top collaborators of Joseph Kohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Kohn. Joseph Kohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bookstaver, P. Brandon, et al.. (2024). Missed Opportunities for Early De-Escalation of Antipseudomonal Beta-Lactam Antimicrobial Therapy in Enterobacterales Bloodstream Infection. Antibiotics. 13(11). 1031–1031. 1 indexed citations
2.
Freeman, Andrew J., et al.. (2024). Oral switch antibiotic therapy in uncomplicated Enterococcus faecalis bloodstream infection. JAC-Antimicrobial Resistance. 7(1). dlaf004–dlaf004. 1 indexed citations
3.
Bookstaver, P. Brandon, Joseph Kohn, Julie Ann Justo, et al.. (2024). The prevalence of gram-negative bacteria with difficult-to-treat resistance and utilization of novel β-lactam antibiotics in the southeastern United States. SHILAP Revista de lepidopterología. 4(1). e35–e35. 1 indexed citations
4.
Bookstaver, P. Brandon, et al.. (2024). Incidence and predictors of complications in Gram-negative bloodstream infection. Infection. 52(5). 1725–1731. 2 indexed citations
6.
Kohn, Joseph, et al.. (2021). Application of Standardized Antimicrobial Administration Ratio as a Motivational Tool within a Multi-Hospital Healthcare System. SHILAP Revista de lepidopterología. 9(1). 32–32. 4 indexed citations
7.
Justo, Julie Ann, et al.. (2021). Impact of follow up blood cultures on outcomes of patients with community-onset gram-negative bloodstream infection. EClinicalMedicine. 34. 100811–100811. 16 indexed citations
8.
Al‐Hasan, Majdi N., et al.. (2021). Clinical Utility and Cost Effectiveness of Long-Acting Lipoglycopeptides Used in Deep-Seated Infections among Patients with Social and Economic Barriers to Care. SHILAP Revista de lepidopterología. 10(1). 1–1. 12 indexed citations
10.
Magagnoli, Joseph, et al.. (2020). Pharmacist-Driven Culture and Sexually Transmitted Infection Testing Follow-Up Program in the Emergency Department. SHILAP Revista de lepidopterología. 8(2). 72–72. 13 indexed citations
11.
Watson, Christopher M., P. Brandon Bookstaver, Joseph Kohn, et al.. (2019). Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection. Infection. 47(4). 571–578. 40 indexed citations
13.
Royer, Julie A., P. Brandon Bookstaver, Julie Ann Justo, et al.. (2019). Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates. International Journal of Antimicrobial Agents. 54(1). 1–7. 19 indexed citations
14.
Al‐Hasan, Majdi N., et al.. (2019). Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors. Journal of Global Antimicrobial Resistance. 22. 87–93. 5 indexed citations
15.
Al‐Jaghbeer, Mohammed, Julie Ann Justo, William B. Owens, et al.. (2018). Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case–case–control study. Infection. 46(4). 487–494. 9 indexed citations
16.
Bookstaver, P. Brandon, et al.. (2016). Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis. Journal of Antimicrobial Chemotherapy. 72(1). 299–304. 57 indexed citations
17.
Justo, Julie Ann, et al.. (2016). Differential effect of prior β-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa. Diagnostic Microbiology and Infectious Disease. 87(1). 87–91. 21 indexed citations
18.
Bookstaver, P. Brandon, et al.. (2015). Impact of fluoroquinolone resistance in Gram-negative bloodstream infections on healthcare utilization. Clinical Microbiology and Infection. 21(9). 843–849. 20 indexed citations
19.
Powles, R, Geoffrey B. Smith, Joseph Kohn, & G. Hamilton Fairley. (1971). Method of Removing Abnormal Protein Rapidly from Patients with Malignant Paraproteinaemias. BMJ. 3(5776). 664–667. 48 indexed citations
20.
Kohn, Joseph. (1966). Modified procedure for pyocine typing.. Journal of Clinical Pathology. 19(4). 403.2–403.2. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026